Larvol Delta - Aviceda-Therapeutics-Raises-Upsized-2075-Million-in-Series-C-Financing-Round-to-Advance-Lead-Program-AVD104-for-Geographic-Atrophy-into-Pivotal-Trials

AVD-104 - Aviceda

https://www.businesswire.com/news/home/20250107381552/en/Aviceda-Therapeutics-Raises-Upsized-207.5-Million-in-Series-C-Financing-Round-to-Advance-Lead-Program-AVD-104-for-Geographic-Atrophy-into-Pivotal-Trials

Jan 7, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next